Author

E M Treshchalina

Observed institution: Russian Cancer Research Center NN Blokhin

ORCID: 0009-0007-6859-1053

Observed ORCID: 0009-0007-6859-1053

OpenAlex ID: A5047246098

[Antitumor properties of mixed coordination compounds of copper (II) and alpha-amino acids].

1979 · E M Treshchalina, A L Konovalova, et al. · PubMed · 16

[Antitumor effect of complex compounds of tetravalent platinum].

1977 · A L Konovalova, M A Presnov, et al. · PubMed · 5

[Preparation and biological properties of basidiomycete aqueous extracts and their mycelial compositions].

2007 · V M Bukhman, E M Treshchalina, et al. · PubMed · 3

[Characteristics of the mechanism of action of complex copper (II) compounds with alpha-amino acids].

1985 · E M Treshchalina, N V Matveĭchuk, et al. · PubMed · 2

[Hematological toxicity of some combined chemotherapy schemes involving aranoza].

2010 · V S Pokrovskiĭ, M I Treshchalin, et al. · PubMed · 1

[Pre-clinical study of combined aranosa, cisplatin and irinotecan in the treatment of experimental lung cancer].

2009 · V S Pokrovskiĭ, N A Lesnaia, et al. · PubMed · 1

[Use of cyto-differentiating agents in oncology].

2006 · S Sh Gadzhieva, E R Polosukhina, et al. · PubMed · 1

[Experimental evaluation of synergism of cisplatin with L-lysine-alpha-oxidase].

2014 · V S Pokrovskiĭ, E V Lukasheva, et al. · PubMed

[Perspectives of developing enzyme-based antitumor drugs].

2011 · V S Pokrovskiĭ, N A Lesnaia, et al. · PubMed

[Growth dynamics of transplantable murine tumors in the course of dicarbamin-protected chemotherapy].

2010 · L A Sedakova, E M Treshchalina, et al. · PubMed

[Final results of cooperative studies of dicarbamine used as a hemoprotector in combination chemotherapy for cancer].

2009 · M B Bychkov, N S Besova, et al. · PubMed

[The hemoprotective effect of Dicarbamin in ovarian cancer patients receiving chemotherapy].

2004 · N T Raĭkhlin, V A Gorbunova, et al. · PubMed

[The effect of Dicarbamin on tumor hemopoietic cell differentiation in Friend's erythroblastoma (histologic and electron microscopic investigation)].

2004 · N T Raĭkhlin, N V Andronova, et al. · PubMed

[Results of a multicenter, phase-II clinical trial of Dicarbamin used to shield leukopoiesis in cancer patients with immunosuppression due to chemotherapy].

2004 · A M Garin, V A Gorbunova, et al. · PubMed

[New models of experimental chemotherapy of tumors].

2001 · E M Treshchalina, N V Andronova, et al. · PubMed

[The effect of a persistent viral infection on natural antitumor resistance].

1991 · M K Mamedov, B F Semenov, et al. · PubMed

[Selection of the models for screening of natural substances with antineoplastic activity].

1990 · E M Treshchalina, L A Sedakova, et al. · PubMed

[Copper (II) glycinate-L-serinate--a representative of a new class of antitumor preparations].

1986 · E M Treshchalina, A L Konovalova, et al. · PubMed

Works count: 18

Citation count: 29

H-index: 3

I10-index: 1